Notify me when Medicxi Ventures Management (Jersey) Ltd files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 5 | $834,980,337 | $0 | $0 | $0 | CNTA, PHAT, NAMS, RAPT, AURA | 13F-HR | 23 Jan 2026, 15:25 |
| Q3 2025 | 5 | $744,418,791 | +$72,057,260 | -$22,352,000 | +$49,705,260 | CNTA, PHAT, NAMS, RAPT, AURA | 13F-HR | 17 Oct 2025, 11:00 |
| Q2 2025 | 5 | $427,250,674 | +$22,352,000 | -$27,269,440 | -$4,917,440 | CNTA, PHAT, NAMS, RAPT THERAPEUTICS INC, AURA | 13F-HR | 08 Jul 2025, 08:49 |
| Q1 2025 | 5 | $437,696,267 | $0 | $0 | $0 | CNTA, NAMS, PHAT, RAPT, AURA | 13F-HR | 11 Apr 2025, 09:30 |
| Q4 2024 | 5 | $529,047,098 | +$35,316,160 | $0 | +$35,316,160 | CNTA, NAMS, PHAT, RAPT, AURA | 13F-HR | 23 Jan 2025, 08:11 |
| Q3 2024 | 4 | $528,890,559 | $0 | $0 | $0 | CNTA, PHAT, NAMS, AURA | 13F-HR | 15 Oct 2024, 13:22 |
| Q2 2024 | 4 | $335,258,328 | $0 | -$52,641,331 | -$52,641,331 | CNTA, PHAT, NAMS, AURA | 13F-HR | 16 Jul 2024, 16:31 |
| Q1 2024 | 5 | $449,227,124 | +$39,333,326 | -$19,406,669 | +$19,926,657 | CNTA, PHAT, NAMS, MRUS, AURA | 13F-HR | 15 Apr 2024, 12:28 |
| Q4 2023 | 5 | $296,229,948 | $0 | -$53,523,545 | -$53,523,545 | CNTA, MRUS, PHAT, NAMS, AURA | 13F-HR | 01 Feb 2024, 08:43 |
| Q3 2023 | 6 | $313,224,690 | $0 | -$13,537,331 | -$13,537,331 | CNTA, PCVX, PHAT, MRUS, AURA | 13F-HR | 18 Oct 2023, 09:39 |
| Q2 2023 | 6 | $356,910,204 | +$28,619,968 | -$7,084,738 | +$21,535,230 | CNTA, PCVX, PHAT, MRUS, AURA | 13F-HR | 19 Jul 2023, 11:04 |
| Q1 2023 | 6 | $233,385,672 | $0 | $0 | $0 | CNTA, PCVX, MRUS, AURA, NAMS | 13F-HR | 27 Apr 2023, 08:51 |
| Q4 2022 | 6 | $238,107,741 | +$21,800,000 | -$20,627,035 | +$1,172,965 | PCVX, CNTA, AURA, PHAT, MRUS | 13F-HR | 31 Jan 2023, 16:16 |
| Q3 2022 | 5 | $240,208,000 | +$372,236 | -$2,528,000 | -$2,155,764 | CNTA, AURA, PCVX, MRUS, PHAT | 13F-HR | 25 Oct 2022, 09:00 |
| Q2 2022 | 6 | $240,803,000 | +$3,231,026 | -$4,790,000 | -$1,558,974 | CNTA, AURA, PCVX, MRUS, PHAT | Restatement | 03 Aug 2022, 11:09 |
| Q1 2022 | 7 | $369,138,000 | +$16,498,251 | $0 | +$16,498,251 | CNTA, AURA, PCVX, MRUS, PHAT | 13F-HR | 12 May 2022, 09:55 |
| Q4 2021 | 7 | $399,584,000 | +$53,869,000 | $0 | +$53,869,000 | CNTA, AURA, MRUS, PCVX, PHAT | 13F-HR | 03 Feb 2022, 09:26 |
| Q3 2021 | 6 | $459,637,000 | $0 | $0 | $0 | CNTA, PHAT, PCVX, MRUS, CMPI | 13F-HR | 10 Nov 2021, 12:47 |
| Q2 2021 | 6 | $557,995,000 | +$398,090,000 | $0 | +$398,090,000 | CNTA, PHAT, PCVX, MRUS, CMPI | 13F-HR | 03 Aug 2021, 06:15 |
| Q1 2021 | 5 | $171,703,000 | $0 | $0 | $0 | PHAT, PCVX, MRUS, CMPI, OBSVF | 13F-HR | 11 May 2021, 11:40 |
| Q4 2020 | 5 | $172,068,000 | $0 | $0 | $0 | PHAT, PCVX, MRUS, CMPI, OBSVF | 13F-HR | 12 Feb 2021, 08:49 |
| Q3 2020 | 5 | $209,408,000 | +$17,284,000 | $0 | +$17,284,000 | PCVX, PHAT, MRUS, CMPI, OBSVF | 13F-HR | 27 Oct 2020, 11:30 |
| Q2 2020 | 4 | $162,707,000 | +$59,663,000 | $0 | +$59,663,000 | PHAT, PCVX, MRUS, OBSVF | 13F-HR | 07 Aug 2020, 06:05 |
| Q1 2020 | 3 | $76,535,000 | $0 | -$70,252,000 | -$70,252,000 | PHAT, MRUS, OBSVF | 13F-HR | 12 May 2020, 12:01 |
| Q4 2019 | 4 | $163,170,000 | $0 | $0 | $0 | THOR, PHAT, MRUS, OBSVF | 13F-HR | 11 Feb 2020, 09:40 |